Citius Pharmaceuticals
CTXR
CTXR
5 hedge funds and large institutions have $112K invested in Citius Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$63K |
| 2 |
2
Goldman Sachs
New York
|
$36K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$6K |
| 4 |
CP
4
Corbenic Partners
Bethlehem,
Pennsylvania
|
$6K |
| 5 |
5
Morgan Stanley
New York
|
$1K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $63K | 19,983 | +19,983 | New |
|
|
2
Goldman Sachs
New York
| $36K | 11,574 | +11,574 | New |
|
|
CP
3
Corbenic Partners
Bethlehem,
Pennsylvania
| $6K | 1,811 | +1,811 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $6K | 1,889 | +1,889 | New |
|
|
5
Morgan Stanley
New York
| $1K | 210 | +210 | New |
|